Proton Med was established in 2016, as a private limited liability company.
Proton Med acts as Representative Office in Albania of the Swiss parent company HealthWatch Swiss AG, whose mission, in synergy with important international partners, is to provide high-quality and costs-effective generic products in various therapeutic areas, to the pharmaceutical markets of South Eastern Europe and beyond.
HealthWatch Swiss holds exclusive partnerships with several large pharmaceutical and biotech manufacturers, among which is Rafarm S.A., a distinguished manufacturer from Greece.
Taking advantage of the intimate knowledge that Proton Med Albania has of the local market, the company also offers a full compliment of pharmaceutical services, including but not limited to, market research, opportunity identification for potential new products, registration and pharmacovigilance procedures, pricing and reimbursement overview, logistics and of course, promotional and sales services.
Over the course of a few years, Proton Med Albania has accomplished a significant increase of its product line, thus establishing a robust portfolio in the Albanian pharmaceutical market.
Starting 2018, Proton Med Albania expanded its activity in Kosovo*, and is currently successfully covering this pharmaceutical market as well, in both fields, tenders and open market.